Deepa Pakianathan

Deepa R.
Pakianathan is Chief Executive Officer at Redd Pharmaceuticals, Inc. since 2019.
Holds the position of Executive Vice Chairman & Treasurer at San Francisco Conservatory of Music.
Independent Director at Karyopharm Therapeutics, Inc. since 2013.
Independent Director at Theravance Biopharma, Inc. since 2020.
Independent Non-Executive Director at Mereo BioPharma Group Plc since 2019.
Independent Director at Palleon Pharmaceuticals, Inc. since 2020.
Independent Director at Freenome, Inc. starting 2026.
Managing Member at Delphi Ventures III LP.
Managing Partner at Delphi Ventures, Inc. since 2001.
Managing Member at Delphi Management Partners VII LLC and Delphi Management Partners VIII LLC since 2013.
Former roles include Director at Phenomix Corp.
(2005–2010), Director at PTC Therapeutics, Inc. (2009–2013), Independent Director at Mereo BioPharma 5, Inc. (2012–2019), Independent Director at Alexza Pharmaceuticals, Inc. (2004–2016), Director at Adiana, Inc., Antipodean Pharmaceuticals, Inc., Ilypsa, Inc., Proteolix, Inc., National Venture Capital Association, NeurAxon, Inc., and FS Development Corp.
and FS Development Corp.
II.
Independent Director at Lundbeck Seattle BioPharmaceuticals, Inc. (2013–2019), Director at Relypsa, Inc. (2007–2012), Lead Independent Director at Calithera Biosciences, Inc. (2012–2023), Postdoctoral Scientist at Genentech, Inc. (1993–1997), Senior Biotechnology Banker at J.P.
Morgan Partners LLC (1998–2001), Research Analyst at Genesis Merchant Group Securities LLC (1997–1998), and Vice President at J.P.
Morgan & Co. Ltd. (1998–2001).
Education includes undergraduate and graduate degrees from the University of Mumbai, graduate and doctorate degrees from Wake Forest University, and graduate studies at the Advanced Centre for Treatment Research & Education in Cancer.